Home > Maligne hematologie > Lymfoïde ziekten > Hodgkin lymfoom > RADAR

RADAR

A randomized phase III trial with a PET response adapted design comparing ABVD +/- ISRT with A2VD +/- ISRT in patients with previously untreated stage IA/IIA Hodgkin lymphoma. https://clinicaltrials.gov/study/NCT04685616?term=NCT04685616&rank=1

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 8-7-2025, 10:10